
Embecta Investors File Lawsuit Over Alleged Insulin Needle Misstatements
A 57.8% single-day stock plunge has triggered a federal securities class action against Embecta Corp. The lawsuit, filed in New Jersey, alleges the medical device company misled shareholders by painting a picture of stability for its insulin pen needle business while facing hidden competitive losses and retail volume declines.























